Best Biotechnology Stocks

Compare the best biotech stocks to buy today.

Biotech stocks are investments in companies that develop products and technologies based on biological research, primarily aimed at advancing healthcare, agriculture, and environmental solutions. These stocks are known for their potential for high growth but also come with significant volatility due to the complex nature of biotechnological development and regulatory environments.

This list includes the largest market-cap stocks in the biotechnology field. View each stock's current price, PE ratio, volume, and recent indicators of potential movement.

On This Page: Biotech Stock Resources FAQ Why Invest in Biotech Stocks

Company	Current Price	PE Ratio	Market Cap	Volume	Average Volume	Indicator(s)
ABBV AbbVie	$177.06 +0.1%	61.48	$312.70 billion	12.46 million	5.55 million	Analyst Revision Positive News High Trading Volume
TMO Thermo Fisher Scientific	$514.05 +0.2%	32.23	$196.62 billion	3.06 million	1.50 million	Positive News High Trading Volume
DHR Danaher	$237.65 +0.8%	45.35	$171.65 billion	4.46 million	2.77 million	Analyst Revision Positive News
VRTX Vertex Pharmaceuticals	$461.71 +2.4%	N/A	$118.90 billion	2.17 million	1.19 million	Positive News
GSK GSK	$34.15 +0.6%	22.18	$70.78 billion	4.15 million	4.16 million
COR Cencora	$244.27 -0.3%	32.53	$48.13 billion	1.48 million	1.40 million	Positive News
What Are Buffett, Dalio, and Druckenmiller So Worried About? (Ad) "This Will Be Worse Than The Great Depression, The Dot-Com Crash, And The 2008 Crisis Combined" According to Dan Ferris, who has predicted nearly every major market crisis of the last 25 years, a new crisis in the US economy could soon cost you 50% of your portfolio or more if you don't prepare your wealth now. Especially if you’re sitting on large gains. Click here to see the new crisis that could abruptly end this current bull market.
TAK Takeda Pharmaceutical	$13.49 +0.8%	23.26	$42.92 billion	1.59 million	1.85 million
CTSH Cognizant Technology Solutions	$80.63 +1.4%	17.84	$39.98 billion	3.07 million	3.84 million	Positive News
IQV IQVIA	$204.02 +1.1%	26.77	$37.03 billion	2.22 million	1.18 million	Analyst Revision
VEEV Veeva Systems	$226.95 +4.8%	60.52	$36.75 billion	2.05 million	958,241	Positive News High Trading Volume
ARGX argenx	$605.66 0.0%	N/A	$36.56 billion	313,493	310,355
ALNY Alnylam Pharmaceuticals	$250.98 +2.5%	N/A	$32.37 billion	1.21 million	878,164	Analyst Revision
BNTX BioNTech	$120.76 +6.7%	N/A	$28.95 billion	1.97 million	818,299	High Trading Volume
ILMN Illumina	$143.82 +2.6%	N/A	$22.81 billion	2.32 million	2.03 million	Positive News
LH Laboratory Co. of America	$241.24 +0.7%	46.66	$20.05 billion	981,981	671,594	Insider Trade News Coverage
ICLR ICON Public	$216.76 +1.2%	24.17	$17.88 billion	1.25 million	736,917
MRNA Moderna	$43.66 +6.2%	N/A	$16.80 billion	15.80 million	4.89 million	Gap Up High Trading Volume
UTHR United Therapeutics	$368.66 -1.1%	16.19	$16.46 billion	515,145	459,227	Positive News
RPRX Royalty Pharma	$26.47 +0.2%	13.72	$15.60 billion	6.83 million	2.65 million	Positive News High Trading Volume
RVTY Revvity	$114.66 +2.3%	55.39	$13.95 billion	1.41 million	843,500	Analyst Forecast Analyst Revision News Coverage
SUZ Suzano	$10.32 -1.6%	16.38	$13.66 billion	2.23 million	1.80 million
PCVX Vaxcyte	$91.70 +3.6%	N/A	$11.43 billion	1.76 million	907,526	Positive News
CTLT Catalent	$61.24 +0.4%	N/A	$11.12 billion	2.64 million	2.04 million
MEDP Medpace	$337.82 +0.0%	29.58	$10.50 billion	306,769	285,344	Analyst Forecast
CRL Charles River Laboratories International	$201.16 +2.8%	25.18	$10.29 billion	612,722	624,951	Positive News
BIO.B Bio-Rad Laboratories	$334.85	N/A	$9.55 billion	6	985
FN Fabrinet	$228.63 -0.8%	27.06	$8.29 billion	606,469	498,653
LEGN Legend Biotech	$42.69 +4.3%	N/A	$7.83 billion	2.11 million	1.12 million
IBB iShares Biotechnology ETF	$139.91 +1.4%	N/A	$7.07 billion	3.32 million	1.46 million	High Trading Volume
LITE Lumentum	$87.20 -2.1%	N/A	$5.99 billion	3.29 million	1.50 million	High Trading Volume
BE Bloom Energy	$25.94 +0.7%	N/A	$5.93 billion	11.09 million	6.52 million	Gap Up
KRYS Krystal Biotech	$194.56 +2.2%	109.92	$5.60 billion	336,297	326,589	Positive News
TGTX TG Therapeutics	$34.61 -1.3%	N/A	$5.39 billion	2.87 million	3.70 million	Analyst Forecast Positive News Gap Up
DNLI Denali Therapeutics	$24.50 -0.8%	N/A	$3.53 billion	1.89 million	1.07 million
IBRX ImmunityBio	$5.04 -1.2%	N/A	$3.51 billion	3.15 million	4.96 million	Gap Up
HTGC Hercules Capital	$18.93 +0.9%	9.37	$3.08 billion	951,824	950,607	Analyst Revision
DYN Dyne Therapeutics	$29.45 -0.8%	N/A	$3.00 billion	1.13 million	1.48 million
VERA Vera Therapeutics	$47.27 -2.2%	N/A	$2.99 billion	519,078	902,797
SWTX SpringWorks Therapeutics	$39.39 +0.9%	N/A	$2.93 billion	1.55 million	1.00 million
FOLD Amicus Therapeutics	$9.72 +0.6%	N/A	$2.90 billion	2.58 million	2.71 million
What Are Buffett, Dalio, and Druckenmiller So Worried About? (Ad) "This Will Be Worse Than The Great Depression, The Dot-Com Crash, And The 2008 Crisis Combined" According to Dan Ferris, who has predicted nearly every major market crisis of the last 25 years, a new crisis in the US economy could soon cost you 50% of your portfolio or more if you don't prepare your wealth now. Especially if you’re sitting on large gains. Click here to see the new crisis that could abruptly end this current bull market.
IOVA Iovance Biotherapeutics	$9.27 +8.4%	N/A	$2.83 billion	9.96 million	7.34 million	Gap Up
TWST Twist Bioscience	$46.40 +9.9%	N/A	$2.75 billion	1.30 million	952,734	Gap Up
ODD Oddity Tech	$48.05 +5.5%	29.30	$2.73 billion	1.19 million	665,281	Positive News
SXI Standex International	$211.52 +3.4%	34.68	$2.56 billion	62,078	56,098	Positive News
AZTA Azenta	$45.58 +0.9%	N/A	$2.23 billion	1.46 million	559,685	High Trading Volume
BEAM Beam Therapeutics	$26.65 +6.4%	N/A	$2.21 billion	1.19 million	1.24 million	Gap Up
WVE Wave Life Sciences	$14.89 +4.3%	N/A	$2.18 billion	1.79 million	1.28 million	Gap Up
APGE Apogee Therapeutics	$43.85 +0.9%	N/A	$1.97 billion	713,694	494,625	Analyst Forecast News Coverage Gap Up
FTRE Fortrea	$20.89 +5.9%	N/A	$1.87 billion	1.40 million	1.29 million	Positive News Gap Up
TXG 10x Genomics	$15.30 +6.9%	N/A	$1.85 billion	2.39 million	1.75 million	Positive News Gap Up
GLPG Galapagos	$27.31 +0.7%	N/A	$1.80 billion	188,667	149,932
EVO Evotec	$4.89 +8.9%	N/A	$1.73 billion	308,458	134,146	Gap Up High Trading Volume
ARVN Arvinas	$25.15 -2.7%	N/A	$1.73 billion	496,195	719,125	Gap Up
RXRX Recursion Pharmaceuticals	$6.00 +5.3%	N/A	$1.72 billion	20.29 million	5.97 million	Gap Up High Trading Volume
VRDN Viridian Therapeutics	$21.03 +4.1%	N/A	$1.67 billion	1.21 million	1.12 million	Analyst Forecast Gap Up
IMCR Immunocore	$32.79 +1.6%	N/A	$1.64 billion	466,802	512,902	Positive News
BCRX BioCryst Pharmaceuticals	$7.27 -4.3%	N/A	$1.51 billion	3.68 million	2.93 million
TPC Tutor Perini	$29.20 +2.4%	N/A	$1.50 billion	467,905	468,588
NVAX Novavax	$9.32 +10.0%	N/A	$1.49 billion	5.53 million	9.66 million	Gap Up
SYRE Spyre Therapeutics	$27.81 +0.4%	N/A	$1.43 billion	869,421	529,122	Gap Up
OCSL Oaktree Specialty Lending	$16.02 +1.1%	22.25	$1.32 billion	991,799	665,549	Dividend Announcement
RCKT Rocket Pharmaceuticals	$14.10 -0.1%	N/A	$1.29 billion	1.21 million	798,488	Insider Trade Gap Up
PHR Phreesia	$20.36 +2.5%	N/A	$1.18 billion	433,536	449,147
THR Thermon Group	$32.24 +0.8%	25.19	$1.09 billion	274,452	195,243	Positive News
TRNS Transcat	$112.22 +2.9%	56.68	$1.03 billion	53,674	55,166
SEPN Septerna	$23.25 +5.7%	N/A	$1.03 billion	179,971	195,894
VIR Vir Biotechnology	$7.44 +4.5%	N/A	$1.02 billion	1.34 million	1.04 million
COGT Cogent Biosciences	$9.19 +0.7%	N/A	$1.02 billion	953,700	1.43 million
UPB Upstream Bio	$18.69 +2.7%	N/A	$1.00 billion	180,027	300,263
ZYME Zymeworks	$14.20 -0.6%	N/A	$984.26 million	332,004	607,250	Analyst Revision
RDW Redwire	$13.76 +4.5%	N/A	$915.59 million	1.08 million	365,178	Gap Up High Trading Volume
SLRC SLR Investment	$16.64 +0.9%	9.40	$907.80 million	202,036	159,239
REPL Replimune Group	$13.26 -11.2%	N/A	$907.25 million	2.93 million	1.06 million	News Coverage High Trading Volume
HQH Abrdn Healthcare Investors	$17.38 +0.8%	N/A	$879.78 million	227,479	159,473	Positive News
CAPR Capricor Therapeutics	$18.82 +1.1%	N/A	$855.75 million	1.31 million	1.15 million
WNC Wabash National	$20.08 +4.0%	N/A	$836.84 million	613,148	490,472	Dividend Announcement
ADPT Adaptive Biotechnologies	$5.58 +19.0%	N/A	$823.50 million	3.86 million	1.43 million	Gap Up High Trading Volume
TYRA Tyra Biosciences	$16.18 +2.2%	N/A	$818.71 million	293,621	194,612
RAPP Rapport Therapeutics	$22.33 -3.3%	N/A	$816.83 million	269,513	156,980	Positive News
PRTA Prothena	$15.08 +3.3%	N/A	$811.44 million	494,629	580,910
CDMO Avid Bioservices	$12.30	N/A	$784.62 million	2.43 million	1.34 million	Positive News
JTEK JPMorgan U.S. Tech Leaders ETF	$76.87 +0.5%	47.95	$782.54 million	82,752	72,736	Positive News
TCPC BlackRock TCP Capital	$9.05	N/A	$774.60 million	451,157	504,116
CRGX CARGO Therapeutics	$16.42 +1.2%	N/A	$755.81 million	231,025	257,266	Gap Up
ANAB AnaptysBio	$24.10 +8.2%	N/A	$733.36 million	744,594	353,507	Gap Up High Trading Volume
TRDA Entrada Therapeutics	$19.04 +1.3%	11.97	$712.48 million	119,646	107,120	Positive News
IMNM Immunome	$11.15 +13.5%	N/A	$695.98 million	2.25 million	779,781	Insider Trade News Coverage Gap Up High Trading Volume
DNTH Dianthus Therapeutics	$23.45 +5.0%	N/A	$694.12 million	338,195	206,903	Gap Up
SLP Simulations Plus	$32.74 +4.5%	66.82	$656.99 million	266,695	137,611
TRML Tourmaline Bio	$23.75 +3.2%	N/A	$609.02 million	402,225	299,320	Positive News
What Are Buffett, Dalio, and Druckenmiller So Worried About? (Ad) "This Will Be Worse Than The Great Depression, The Dot-Com Crash, And The 2008 Crisis Combined" According to Dan Ferris, who has predicted nearly every major market crisis of the last 25 years, a new crisis in the US economy could soon cost you 50% of your portfolio or more if you don't prepare your wealth now. Especially if you’re sitting on large gains. Click here to see the new crisis that could abruptly end this current bull market.
LAB Standard BioTools	$1.62 +1.3%	N/A	$603.06 million	1.61 million	2.46 million
GRAL Grail	$17.68 +7.2%	N/A	$594.05 million	1.02 million	1.08 million
OABI OmniAb	$4.15 +5.9%	N/A	$586.05 million	638,413	506,143
IGMS IGM Biosciences	$9.40 +5.7%	N/A	$558.92 million	259,505	308,554	Gap Up
SANA Sana Biotechnology	$2.48 -5.0%	N/A	$553.71 million	1.94 million	2.14 million
ABVX ABIVAX Société Anonyme	$8.50 -3.2%	N/A	$537.97 million	289,202	94,169	Gap Up High Trading Volume
PROK ProKidney	$1.83 +8.3%	N/A	$533.74 million	380,311	702,718	Gap Up
PRTC PureTech Health	$22.07 -2.1%	N/A	$528.36 million	3,668	4,131
GLUE Monte Rosa Therapeutics	$8.46 -0.4%	N/A	$519.78 million	803,503	758,907
CELC Celcuity	$13.90 +5.4%	N/A	$516.11 million	309,452	279,757

More Biotech Resources

For those interested in diving deeper into the biotech sector, here are a couple of valuable resources:

Biotech Stocks Frequently Asked Questions

Biotech stocks represent shares of companies in the biotechnology sector, which focuses on using biological processes, organisms, or systems to develop products that improve health, fight diseases, and benefit the environment. This sector includes companies that work on drug development, genetic research, biologically derived materials, and more. Due to the innovative and often breakthrough nature of their work, biotech stocks are known for their volatility but also for their potential to offer substantial returns.

Prominent players in the biotech sector include large, well-established companies such as Amgen, Gilead Sciences, and Biogen, which have multiple products on the market and solid research pipelines. Younger companies like Moderna and Regeneron are also notable, especially for their roles in developing treatments and vaccines at an accelerated pace in response to global health crises. These companies represent a mix of stable investments and high-growth potentials within the biotech industry.

While biotech exists in other areas, the majority of the biotech stocks are in the medical and agricultural sectors. Investors might choose individual stocks of companies they believe have potential based on their pipelines or existing products. However, due to the high risk associated with the biotech sector, many opt to diversify their exposure through biotech ETFs or mutual funds, which include a range of companies from startups to established leaders. This strategy can mitigate some of the risks while allowing investors to benefit from the sector's overall growth.

Before investing in biotech stocks, consider the unique risks of this sector, including high development costs, regulatory hurdles, and the binary nature of clinical trial results, which can dramatically affect a company's stock price. Investors should be prepared for volatility and have a tolerance for risk. It is also crucial to research and understand the specific focus areas of biotech companies, as these can vary widely from medical devices and pharmaceuticals to agricultural and environmental biotechnologies. Consulting with a financial advisor who understands the biotech sector can provide valuable insights and guidance tailored to your financial goals.

(Ad)

"This Will Be Worse Than The Great Depression, The Dot-Com Crash, And The 2008 Crisis Combined" According to Dan Ferris, who has predicted nearly every major market crisis of the last 25 years, a new crisis in the US economy could soon cost you 50% of your portfolio or more if you don't prepare your wealth now. Especially if you’re sitting on large gains.

Top Biotech Stocks: Exploring Innovation Opportunities

Written by Jessica Mitacek | Reviewed by Don Miller

Updated June 6, 2024 | Reviewed on June 6, 2024

Biotech stocks continue to be a robust sector of the stock market. An aging population with increasing healthcare demands, combined with rapidly growing and improving technology, supports the growth of biotech stocks. The biotech industry is highly competitive and incredibly diverse, with a few companies managing to stand out and make a name for themselves.

Biotech stocks can be highly volatile, and some investors choose to diversify their exposure through biotech-focused exchange traded funds (ETFs) or mutual funds to mitigate some of the risks while allowing investors to benefit from the sector's overall growth. Some top ETFs tracking companies in the biotech sector are the SPDR S&P Biotech ETF (NYSEARCA: XBI), iShares Biotechnology ETF (NASDAQ : IBB), and ALPS Medical Breakthroughs ETF (NYSEARCA: SBIO).

Let’s take a look at some of the top biotech companies in the world.

Vertex Pharmaceuticals (NASDAQ: VRTX)

Vertex focuses on treatments for cystic fibrosis and has seen strong growth in recent years. The company ranks highly among biotech companies and is exploring gene editing as a treatment for muscular dystrophy and sickle cell anemia. Vertex’s rapid profit growth makes it an attractive investment.

Regeneron Pharmaceuticals (NASDAQ: REGN)

Regeneron has a robust pipeline of drugs, including successful treatments like EYLEA for eye diseases and Dupixent for autoimmune diseases, as well as promising candidates like odronextamab for follicular lymphoma. The company invests heavily in R&D, leading to breakthroughs in treatments for serious conditions, positioning it as a leader in the biotech industry.

Moderna (NASDAQ: MRNA)

Known for its COVID-19 vaccine, Moderna is developing new vaccines and treatments including a flu/COVID-19 combination vaccine expected by 2025 and an RSV vaccine candidate that could be approved soon. The company is investing heavily in mRNA technology for other vaccines and treatments.

Amgen (NASDAQ: AMGN)

As one of the largest biotech companies, Amgen has a diverse portfolio of drugs for various conditions. The company is valued at over $100 billion and offers a generous dividend yield, making it a stable investment.

BioMarin Pharmaceutical (NASDAQ: BMRN)

BioMarin focuses on rare diseases and gene therapies. Its significant products include Vimizim, Voxzogo, and Roctavian, which have shown substantial sales growth.

Gilead Sciences (NASDAQ: GILD)

A leader in both HIV and liver diseases, Gildead is known for its revolutionary treatment for Hepatitis C released in 2014. The company has a strong pipeline with promising therapies in development, particularly in oncology and virology, which are expected to drive future growth. Gilead has also made strategic acquisitions to bolster its R&D capabilities and expand its market presence.

Legend Biotech (NASDAQ: LEGN)

This clinical-stage biopharma company specializes in cell therapies for cancer. Its breakthrough CAR-T cell therapy, Carvykti, has shown significant efficacy in treating multiple myeloma. In addition, the company has collaborated with Johnson & Johnson’s Janssen unit.

About The Editor

Jessica Mitacek

Associate Editor & Contributing Author

Market Analysis and Research

Learn More

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Best Biotechnology Stocks

More Biotech Resources

Biotech Stocks Frequently Asked Questions

Top Biotech Stocks: Exploring Innovation Opportunities

Jessica Mitacek

Associate Editor & Contributing Author

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Best Biotechnology Stocks

More Biotech Resources

Biotech Stocks Frequently Asked Questions

What Are Biotech Stocks?

What Are the Leading Companies in the Biotech Sector?

How Can I Invest in Biotech Stocks?

What Should I Consider Before Investing in Biotech Stocks?

Top Biotech Stocks: Exploring Innovation Opportunities

Jessica Mitacek

Associate Editor & Contributing Author

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools